Intron associated with myotonic dystrophy type 2 and methods of use
AssigneeRegents of the University of Minnesota
InventorsLaura P. W. Ranum, John W. Day, Christina Liquori
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
Claims8
An isolated polynucleotide comprising about nucleotides 17501-17701 of SEQ ID NO:1 and an at risk repeat tract, and the full complements thereof.
An isolated polynucleotide comprising about nucleotides 17858-18062 of SEQ ID NO:1 and an at risk repeat tract, and the full complements thereof.
Dependencies are inferred from the claim text.